5-methylpyrazole-3-carboxylic acid has been researched along with 3-hydroxyquinolin-2(1h)-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, SL; Bohanon, MJ; Borzilleri, KA; Chrunyk, BA; Downs, JT; Duplantier, AJ; El-Kattan, A; Hu, LY; James, LC; Liu, S; Lu, J; Maklad, N; Mansour, MN; Mente, S; Piotrowski, MA; Sakya, SM; Sheehan, S; Steyn, SJ; Strick, CA; Williams, VA; Zhang, L | 1 |
| Alt, J; Burzynski, C; Rais, R; Slusher, BS; Tsukamoto, T; Zimmermann, SC | 1 |
2 other study(ies) available for 5-methylpyrazole-3-carboxylic acid and 3-hydroxyquinolin-2(1h)-one
| Article | Year |
|---|---|
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
Topics: Animals; Cerebellum; Crystallography, X-Ray; D-Amino-Acid Oxidase; Drug Discovery; Drug Evaluation, Preclinical; Humans; Hydroxyquinolines; Male; Mice; Rats; Rats, Sprague-Dawley; Serine; Structure-Activity Relationship | 2009 |
Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors.
Topics: | 2014 |